Artivion AORT North America — Total revenues
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Artivion in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Artivion’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Artivion's north america — total revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Artivion's north america — total revenues?
- Artivion (AORT) reported north america — total revenues of $58.7M in Q1 2026.
- How has Artivion's north america — total revenues changed year-over-year?
- Artivion's north america — total revenues increased by 22.8% year-over-year, from $47.79M to $58.7M.
- What is the long-term trend for Artivion's north america — total revenues?
- Over 4 years (2021 to 2025), Artivion's north america — total revenues has grown at a 8.9% compound annual growth rate (CAGR), from $157.88M to $221.74M.
- What does north america — total revenues mean?
- This metric represents the total gross revenue generated from the sale of cardiac and vascular surgical products within the North American geographic market. It serves as a primary indicator of the company's market penetration and commercial success in its largest operational region. Tracking this figure allows investors to assess regional growth trends and the effectiveness of the company's aortic-centric product portfolio in the North American healthcare landscape.